Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

Overview of attention for article published in Frontiers in Cellular and Infection Microbiology, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 11 X users

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 64 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 14 X posts from 11 X users, with an upper bound of 32,055 followers.

RT @edenhelmi: @IdVilchez @GermHunterMD Interesting point on the agent and the low pH “Furthermore, ibrexafungerp has shown efficacy in lo…

31 May 2022

Reply Repost Favourite

@IdVilchez @GermHunterMD Interesting point on the agent and the low pH “Furthermore, ibrexafungerp has shown efficacy in low pH environments, which suggests its potential effectiveness in treating vulvovaginal candidiasis” https://t.co/v4w7qWT5lH

31 May 2022

Reply Repost Favourite

RT @MFT_NAC: Candida glabrata has become a growing concern for mucosal and systemic bloodstream infections and is particularly worrisome be…

20 Apr 2022

Reply Repost Favourite

RT @MFT_NAC: Candida glabrata has become a growing concern for mucosal and systemic bloodstream infections and is particularly worrisome be…

20 Apr 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.